Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Rats overexpressing the dopamine transporter display behavioral and neurobiological abnormalities with relevance to repetitive disorders.

Hadar R, Edemann-Callesen H, Reinel C, Wieske F, Voget M, Popova E, Sohr R, Avchalumov Y, Priller J, van Riesen C, Puls I, Bader M, Winter C.

Sci Rep. 2016 Dec 15;6:39145. doi: 10.1038/srep39145.

2.

Association of Dystrobrevin-Binding Protein 1 Polymorphisms with Sustained Attention and Set-Shifting in Schizophrenia Patients.

Bakanidze G, Brandl EJ, Hutzler C, Aurass F, Onken S, Rapp MA, Puls I.

Neuropsychobiology. 2016;74(1):41-47. doi: 10.1159/000450550. Epub 2016 Nov 1.

PMID:
27798936
3.

A case series in patients with enteropathy and granulomatous diseases.

Kruis T, Jöhrens K, Moos V, Puls I, Siegmund B, Daum S, Schumann M.

BMC Gastroenterol. 2015 May 23;15:62. doi: 10.1186/s12876-015-0292-4.

4.

Genetics of alcohol dependence: a review of clinical studies.

Samochowiec J, Samochowiec A, Puls I, Bienkowski P, Schott BH.

Neuropsychobiology. 2014;70(2):77-94. doi: 10.1159/000364826. Epub 2014 Oct 30. Review.

PMID:
25359488
5.

Association of the Nicotinic Receptor α7 Subunit Gene (CHRNA7) with Schizophrenia and Visual Backward Masking.

Bakanidze G, Roinishvili M, Chkonia E, Kitzrow W, Richter S, Neumann K, Herzog MH, Brand A, Puls I.

Front Psychiatry. 2013 Oct 22;4:133. doi: 10.3389/fpsyt.2013.00133. eCollection 2013.

6.

Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain.

Brandl EJ, Frydrychowicz C, Tiwari AK, Lett TA, Kitzrow W, Büttner S, Ehrlich S, Meltzer HY, Lieberman JA, Kennedy JL, Müller DJ, Puls I.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Aug 7;38(2):134-41. doi: 10.1016/j.pnpbp.2012.03.001. Epub 2012 Mar 8.

PMID:
22426215
7.

Smoking, but not malnutrition, influences promoter-specific DNA methylation of the proopiomelanocortin gene in patients with and without anorexia nervosa.

Ehrlich S, Walton E, Roffman JL, Weiss D, Puls I, Doehler N, Burghardt R, Lehmkuhl U, Hillemacher T, Muschler M, Frieling H.

Can J Psychiatry. 2012 Mar;57(3):168-76.

PMID:
22398003
8.

A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia.

Tiwari AK, Zai CC, Likhodi O, Lisker A, Singh D, Souza RP, Batra P, Zaidi SH, Chen S, Liu F, Puls I, Meltzer HY, Lieberman JA, Kennedy JL, Müller DJ.

Neuropsychopharmacology. 2010 May;35(6):1315-24. doi: 10.1038/npp.2009.235. Epub 2010 Jan 27.

9.

Neurotransmitter systems in alcohol dependence.

Heinz A, Beck A, Wrase J, Mohr J, Obermayer K, Gallinat J, Puls I.

Pharmacopsychiatry. 2009 May;42 Suppl 1:S95-S101. doi: 10.1055/s-0029-1214395. Epub 2009 May 11. Review.

PMID:
19434561
10.

5-HTT genotype effect on prefrontal-amygdala coupling differs between major depression and controls.

Friedel E, Schlagenhauf F, Sterzer P, Park SQ, Bermpohl F, Ströhle A, Stoy M, Puls I, Hägele C, Wrase J, Büchel C, Heinz A.

Psychopharmacology (Berl). 2009 Aug;205(2):261-71. doi: 10.1007/s00213-009-1536-1. Epub 2009 Apr 23.

PMID:
19387615
11.

A model comparison of COMT effects on central processing of affective stimuli.

Puls I, Mohr J, Wrase J, Vollstädt-Klein S, Leménager T, Vollmert C, Rapp M, Obermayer K, Heinz A, Smolka MN.

Neuroimage. 2009 Jul 1;46(3):683-91. doi: 10.1016/j.neuroimage.2009.02.033. Epub 2009 Mar 4.

PMID:
19268548
12.

[Genetics of weight gain associated with antipsychotic medications].

Müller DJ, Peter C, Puls I, Brandl EJ, Lang UE, Gallinat J, Heinz A.

Nervenarzt. 2009 May;80(5):556-63. doi: 10.1007/s00115-008-2650-8. Review. German.

PMID:
19212741
13.

The concept of endophenotypes in psychiatric diseases meeting the expectations?

Puls I, Gallinat J.

Pharmacopsychiatry. 2008 Sep;41 Suppl 1:S37-43. doi: 10.1055/s-2008-1081462. Review.

PMID:
18756419
14.

Catechol-O-methyltransferase val158met genotype influences neural processing of reward anticipation.

Schmack K, Schlagenhauf F, Sterzer P, Wrase J, Beck A, Dembler T, Kalus P, Puls I, Sander T, Heinz A, Gallinat J.

Neuroimage. 2008 Oct 1;42(4):1631-8. doi: 10.1016/j.neuroimage.2008.06.019. Epub 2008 Jun 25.

PMID:
18634888
15.

Synergistic effects of the dopaminergic and glutamatergic system on hippocampal volume in alcohol-dependent patients.

Puls I, Mohr J, Wrase J, Priller J, Behr J, Kitzrow W, Makris N, Breiter HC, Obermayer K, Heinz A.

Biol Psychol. 2008 Sep;79(1):126-36. doi: 10.1016/j.biopsycho.2008.03.001. Epub 2008 Mar 18.

PMID:
18423838
16.

Molecular mechanisms of schizophrenia.

Lang UE, Puls I, Muller DJ, Strutz-Seebohm N, Gallinat J.

Cell Physiol Biochem. 2007;20(6):687-702. Review.

17.

Genetic research with intermediate phenotypes: phenocopies, perspectives and pitfalls.

Heinz A, Friedel E, Müller DJ, Puls I, Wrase J.

Addiction. 2007 Nov;102(11):1696-7. No abstract available.

PMID:
17935576
18.

Serotonergic dysfunction: brain imaging and behavioral correlates.

Wrase J, Reimold M, Puls I, Kienast T, Heinz A.

Cogn Affect Behav Neurosci. 2006 Mar;6(1):53-61. Review.

PMID:
16869229
19.

A motor neuron disease-associated mutation in p150Glued perturbs dynactin function and induces protein aggregation.

Levy JR, Sumner CJ, Caviston JP, Tokito MK, Ranganathan S, Ligon LA, Wallace KE, LaMonte BH, Harmison GG, Puls I, Fischbeck KH, Holzbaur EL.

J Cell Biol. 2006 Feb 27;172(5):733-45.

20.

Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations.

Sivakumar K, Kyriakides T, Puls I, Nicholson GA, Funalot B, Antonellis A, Sambuughin N, Christodoulou K, Beggs JL, Zamba-Papanicolaou E, Ionasescu V, Dalakas MC, Green ED, Fischbeck KH, Goldfarb LG.

Brain. 2005 Oct;128(Pt 10):2304-14. Epub 2005 Jul 13.

PMID:
16014653
21.

Distal spinal and bulbar muscular atrophy caused by dynactin mutation.

Puls I, Oh SJ, Sumner CJ, Wallace KE, Floeter MK, Mann EA, Kennedy WR, Wendelschafer-Crabb G, Vortmeyer A, Powers R, Finnegan K, Holzbaur EL, Fischbeck KH, Ludlow CL.

Ann Neurol. 2005 May;57(5):687-94.

22.

Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter.

Heinz A, Braus DF, Smolka MN, Wrase J, Puls I, Hermann D, Klein S, Grüsser SM, Flor H, Schumann G, Mann K, Büchel C.

Nat Neurosci. 2005 Jan;8(1):20-1. Epub 2004 Dec 12.

PMID:
15592465
23.

[Genetic and pharmacological effects on prefrontal cortical function in schizophrenia].

Heinz A, Braus DF, Romero B, Gallinat J, Puls I, Juckel G, Weinberger DR.

Nervenarzt. 2004 Sep;75(9):845-56. Review. German.

PMID:
15372159
24.

Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence.

Heinz A, Goldman D, Gallinat J, Schumann G, Puls I.

Psychopharmacology (Berl). 2004 Aug;174(4):561-70. Epub 2004 May 18. Review.

PMID:
15148564
25.

DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4).

Chen YZ, Bennett CL, Huynh HM, Blair IP, Puls I, Irobi J, Dierick I, Abel A, Kennerson ML, Rabin BA, Nicholson GA, Auer-Grumbach M, Wagner K, De Jonghe P, Griffin JW, Fischbeck KH, Timmerman V, Cornblath DR, Chance PF.

Am J Hum Genet. 2004 Jun;74(6):1128-35. Epub 2004 Apr 21.

26.

Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V.

Antonellis A, Ellsworth RE, Sambuughin N, Puls I, Abel A, Lee-Lin SQ, Jordanova A, Kremensky I, Christodoulou K, Middleton LT, Sivakumar K, Ionasescu V, Funalot B, Vance JM, Goldfarb LG, Fischbeck KH, Green ED.

Am J Hum Genet. 2003 May;72(5):1293-9. Epub 2003 Apr 10.

27.

Mutant dynactin in motor neuron disease.

Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, Mann E, Floeter MK, Bidus K, Drayna D, Oh SJ, Brown RH Jr, Ludlow CL, Fischbeck KH.

Nat Genet. 2003 Apr;33(4):455-6. Epub 2003 Mar 10.

PMID:
12627231
28.

Prognostic and diagnostic value of global cerebral blood flow volume and cerebral transit time in acute stroke.

Ruprecht-Dörfler P, Brechtelsbauer D, Schliesser M, Puls I, Becker G.

Ultrasound Med Biol. 2002 Nov-Dec;28(11-12):1405-11.

PMID:
12498935
29.

Progressive sudomotor dysfunction in amyotrophic lateral sclerosis.

Beck M, Giess R, Magnus T, Puls I, Reiners K, Toyka KV, Naumann M.

J Neurol Neurosurg Psychiatry. 2002 Jul;73(1):68-70.

30.

Disease progression in amyotrophic lateral sclerosis: predictors of survival.

Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka KV.

Muscle Nerve. 2002 May;25(5):709-14.

PMID:
11994965
31.

Vaccination and FMD.

van't HK, Luttikhuis RO, Mol L, Puls I.

Vet Rec. 2002 Feb 2;150(5):156. No abstract available.

PMID:
11871673
32.

Impact of the human genome sequence on neurology and neuroscience.

Puls I, Lieberman AP, Fischbeck KH.

Arch Neurol. 2001 Nov;58(11):1750-1. No abstract available.

PMID:
11708978
33.

Mining the genome for causes and cures of neurological disease.

Lieberman AP, Puls I, Fischbeck KH.

Trends Pharmacol Sci. 2001 Apr;22(4):161-2. No abstract available.

PMID:
11282405
34.

Early postoperative transcranial sonography (TCS), CT, and MRI after resection of high grade glioma: evaluation of residual tumour and its influence on prognosis.

Mäurer M, Becker G, Wagner R, Woydt M, Hofmann E, Puls I, Lindner A, Krone A.

Acta Neurochir (Wien). 2000;142(10):1089-97.

PMID:
11129529
35.

Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis.

Giess R, Naumann M, Werner E, Riemann R, Beck M, Puls I, Reiners C, Toyka KV.

J Neurol Neurosurg Psychiatry. 2000 Jul;69(1):121-3.

36.

Transcranial sonography of the brain parenchyma: comparison of B-mode imaging and tissue harmonic imaging.

Puls I, Berg D, Mäurer M, Schliesser M, Hetzel G, Becker G.

Ultrasound Med Biol. 2000 Feb;26(2):189-94.

PMID:
10722907
37.

Measurement of cerebral blood flow volume by extracranial sonography.

Dörfler P, Puls I, Schliesser M, Mäurer M, Becker G.

J Cereb Blood Flow Metab. 2000 Feb;20(2):269-71.

PMID:
10698063
38.

[Clenbuterol in amyotrophic lateral sclerosis. No indication for a positive effect].

Puls I, Beck M, Giess R, Magnus T, Ochs G, Toyka KV.

Nervenarzt. 1999 Dec;70(12):1112-5. Review. German.

PMID:
10637819
39.

Volume reduction in cerebral blood flow in patients with vascular dementia.

Scheel P, Puls I, Becker G, Schöning M.

Lancet. 1999 Dec 18-25;354(9196):2137.

PMID:
10609827
40.

Diagnostic impact of cerebral transit time in the identification of microangiopathy in dementia: A transcranial ultrasound study.

Puls I, Hauck K, Demuth K, Horowski A, Schliesser M, Dörfler P, Scheel P, Toyka KV, Reiners K, Schöning M, Becker G.

Stroke. 1999 Nov;30(11):2291-5.

PMID:
10548660
41.

Cerebral arteriovenous transit time (CTT): a sonographic assessment of cerebral microcirculation using ultrasound contrast agents.

Puls I, Becker G, Mäurer M, Müllges W.

Ultrasound Med Biol. 1999 May;25(4):503-7.

PMID:
10386724
42.

[The treatment of arrhythmias in infants and children using propafenone].

Dressler F, Grävinghoff L, Grütte E, Jüngst BK, Liersch R, Nomayo H, Puls I, Rautenburg HW, Schmaltz A, Schumacher G, et al.

Monatsschr Kinderheilkd. 1985 Mar;133(3):154-7. German.

PMID:
4010670
43.

[Plasma ammonia concentrations in mucoviscidosis].

Puls I, Simon G, Szám I.

Z Gesamte Inn Med. 1983 Aug 1;38(15):422-5. German.

PMID:
6636906

Supplemental Content

Support Center